Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains

Viral Immunology

Volumn 19, Issue 1, 2006, Pages 33-41

  Lim, C S ^a   Chua, John J E ^a   Wilkerson, Jamica ^b   Chow, Vincent T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b WINSTON SALEM STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; DENGUE VIRUS ANTIGEN; EPITOPE; FLAVIVIRUS VACCINE; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE; YELLOW FEVER VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS; DENGUE VIRUS 2; ENZYME IMMUNOASSAY; IMMUNIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEROTYPE; TREATMENT OUTCOME; VIRUS ENVELOPE; VIRUS STRAIN;

ALBINISM; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CROSS REACTIONS; DENGUE; DENGUE VIRUS; FLAVIVIRUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; DENGUE VIRUS; DENGUE VIRUS TYPE 2; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS;

EID: 33645463479     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.33     Document Type: Article

References (47)

1. Allwinn, R., H.W. Doerr, P. Emmerich, H. Schmitz, and W. Preiser. 2002. Cross-reactivity in flavivirus serology: new implications of an old finding? Med. Microbiol. Immunol. 190:199-202.
2. A-Nuegoonpipat, A., A. Berlioz-Arthaud, V. Chow, T. Endy, K. Lowry, Q. le Mai, T.U. Ninh, A. Pyke, M. Reid, J.M. Reynes, S.T. Su Yun, H.M. Thu, S.S. Wong, E.C. Holmes, and J. Aaskov. Sustained transmission of dengue virus type 1 in the Pacific due to repeated introductions of different Asian strains. 2004. Virology 329:505-512.
3. Barrett, A.D. 1997. Japanese encephalitis and dengue vaccines. J. Virol. 71:2921-2927.
4. Bernardo, L., A. Yndart, S. Vazquez, L. Morier, and M.G. Guzman. 2005. Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice. Clin. Diagn. Lab. Immunol. 12:361-362.
5. Brandriss, M.W., J.J. Schlesinger, and E.E. Walsh. 1990. Immunogenicity of a purified fragment of 17D yellow fever envelope protein. J. Infect. Dis. 161:1134-1139.
6. Bray M., R. Men, I. Tokimatsu, and C.J. Lai. 1998. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol. 72:1647-1651.
7. Brinton, M.A., I. Kurane, A. Mathew, L.L. Zeng, P.Y. Shi, A. Rothman, and F.A. Ennis. 1998. Immune mediated and inherited defences against flaviviruses. Clin. Diagn. Virol. 10:129-139.
8. Carey, D.E., and R.M. Myers. 1968. Japanese encephalitis studies in Vellore, South India. Part III. Neutralizing activity of human survey sera. Indian J. Med. Res. A. 56:1330-1339.
9. Chow, V.T. 1997. Molecular diagnosis and epidemiology of dengue virus infection. Ann. Acad. Med. 26:820-826.
10. Chow, V.T., Y.C. Chan, R. Yong, K.M. Lee, L.K. Lim, Y.K. Chung, S.G. Lam-Phua, and B.T. Tan. 1998. Monitoring of dengue viruses in field-caught Aedes aegypti and Aedes albopictus mosquitoes by a type-specific polymerase chain reaction and cycle sequencing. Am. J. Trop. Med. Hyg. 58:578-586.
11. Chow, V.T., C.S. Lim, M.C. Phoon, and H.C. Tan. A seroprevalence survey of dengue virus infection in healthy Singapore university undergraduates by enzyme immunoassay and plaque reduction neutralization test. Dengue Bull. (in press).
12. Chow, V.T., C.L. Seah, and Y.C. Chan. 1994. Comparative analysis of NS3 sequences of temporally separated dengue 3 virus strains isolated from southeast Asia. Intervirology 37:252-258.
13. Chow, V.T., R. Yong, and Y.C. Chan. 1997. Sequence analyses of NS3 genes of recent Pakistan and Singapore strains of dengue virus types 1 and 2. Res. Virol. 148:17-20.
14. Daffis S., R.E. Kontermann, J. Korimbocus, H. Zeller, H.D. Klenk, and J. Ter Meulen. 2005. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants. Virology 337:262-272.
15. Diamond, M.S., D. Edgil, T.G. Roberts, B. Lu, and E. Harris. 2000. Infections of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74:7814-7823.
16. Feighny, R.J., J. Burrous, J. McCown, C. Hoke, and R. Putnak. 1992. Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice. Am. J. Trop. Med. Hyg. 47:405-412.
17. Goverdhan, M.K., A.B. Kulkarni, A.K. Gupta, C.D. Tupe, and J.J. Rodrigues. 1992. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol. 36:277-283.
18. Hahn, C.S., J.M. Darlymple, J.H. Strauss, and C.M. Rice. 1987. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl. Acad. Sci. U.S.A. 84:2019-2023.
19. Heinz, F.X. 1986. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:103-168.
20. Henchal, E.A., and J.R. Putnak. 1990. The dengue viruses. Clin. Microbiol. Rev. 3:376-396.
21. Holzmann, H., F.X. Heinz, C.W. Mandl, F. Guirakhoo, and C. Funz. 1990. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 64:5156-5159.
22. Innis, B.L., A. Nisalak, S. Nimmanitya, S. Kusalerdchariya, V. Chongswasdi, S. Suntayakom, P. Puttisri, and S. Hoke. 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
23. Jacobs, M. 2000. Dengue: Emergence as a global public health problem and prospects for control. Trans. R. Soc. Trop. Med. Hyg. 94:7-8.
24. Jiang, W.R., A. Lowe, S. Higgs, H. Reid, and E.A. Gould. 1993. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol. 74:931-935.
25. Leclerc, C., E. Deriaud, F. Megret, J.P. Briand, M.H. Van Regenmortel, and V. Deubel. 1993. Identification of helper T cell epitopes of dengue virus E-protein. Mol. Immunol. 30:613-625.
26. Leitmeyer, K.C., D.W. Vaughn, D.M. Watts, R. Salas, I. Villalobos, de Chacon, C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738-4747.
27. Lobigs, M., R. Usha, A. Nestorowicz, I.D. Marshall, R.C. Weir, and L. Dalgarno. 1990. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176:587-595.
28. Lok, S.M., M.L. Ng, and J. Aaskov. 2001. Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralization by IgM antibody. J. Med. Virol. 65:315-323.
29. Makino, Y., M. Tadano, M. Saito, N. Maneekarn, N. Sittisombut, V. Sirisanthana, B. Poneprasert, and T. Fukunaga. 1994. Studies on serological cross-reaction in sequential flavivirus infections. Microbiol. Immunol. 38:951-955.
30. McBride, W.J., and H. Bielefeldt-Ohmann. 2000. Dengue viral infections pathogenesis and epidemiology. Microbes Infect. 2:1041-1045.
31. Modis, Y., S. Ogata, D. Clements, and S.C. Harrison. 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 100:6986-6991.
32. Monath, T.P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91: 2395-2400.
33. Mongkolsapaya, J., W. Dejnirattisai, X.N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, P.T. Yenchitsomanus, A. McMichael, P. Malasit, and G. Screaton. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:921-927.
34. Nitayaphan, S., J.A. Grant, J.A. Chang, G.J. Chang, and D.W. Trent. 1990. Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis and its attenuated vaccine derivative, SA-14-D. Virology 177:541-552.
35. Pandey, B.D., and A. Igarashi. 2000. Severity-related molecular differences among nineteen strains of dengue type 2 virus. Microbiol. Immunol. 44:179-188.
36. Pletnev, A.G., M. Bray, J. Huggins, and C.J. Lai. 1992. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. USA 89:10532-10536.
37. Ramakrishna C., V. Ravi, A. Desai, D.K. Subbakrishna, S.K. Shankar, and A. Chandramuki. 2003. T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used. J. Gen. Virol. 84:1559-1567.
38. Rey, F.A., F.X. Heinz, C. Mandl, C. Kunz, and S.C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2A resolution. Nature 375:291-298.
39. Rico-Hesse, R., L.M. Harrison, R.A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M.T. de Mesa, R.M. Nogueira, and A.T. da Rosa. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. 1997. Virology 230:244-251.
40. Rothman, A.L. 2004. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113:946-951.
41. Seligman, S.J., and E.A. Gould. 2004. Live flavivirus vaccines: reasons for caution. Lancet 363:2073-2075.
42. Srivastava, A.K., J.R. Putnak, R.L. Warren, and C.H. Hoke. 1995. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection. Vaccine 13:1251-1258.
43. Twiddy, S.S., J.J. Farrar, N. Vinh Chau, B. Wills, E.A. Gould, T. Gritsun, G. Lloyd, and E.C. Holmes. Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. 2002. Virology 298:63-72.
44. Welsh, R.M., and A.L. Rothman. 2003. Dengue immune response: low affinity, high febrility. Nat. Med. 9:820-822.
45. Wisseman, C.L., M. Kitaoka, and T. Tamiya. 1966. Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine. Am. J. Trop. Med. Hyg. 15:588-600.
46. Yamshchikov, G., V. Borisevich, C.W. Kwok, R. Nistler, J. Kohlmeier, A. Seregin, E. Chaporgina, S. Benedict, and V. Yamshchikov. 2005. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus. Vaccine 23:4785-4792.
47. Zhang, Y., W. Zhang, S. Ogata, D. Clements, J. Strauss, T. Baker, R. Kuhn, and M. Rossmann. 2004. Conformational changes of the flavivirus E glycoprotein. Structure 12:1607-1618.